Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vineet LaboratoriesBOM:543298 -0.73%56 3-Year ROIIC % is 37.79 as of Mar. 2026, which is 642% above its 10-year median of 5.09. GuruFocus rates BOM:543298 with a GF Score™ of 56/100 and a GF Value™ of ₹10.04 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,536 Chemicals companies, Vineet Laboratories ranks better than 84.77% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Vineet Laboratories's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 37.79%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Vineet Laboratories's 3-Year ROIIC % or its related term are showing as below:
BOM:543298's 3-Year ROIIC % is ranked better than 84.77% of 1536
companies
in the Chemicals industry
Industry Median: 0.14
vs BOM:543298: 37.79
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Vineet Laboratories 3-Year ROIIC % Related Terms
Vineet Laboratories 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Vineet Laboratories's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Vineet Laboratories's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vineet Laboratories 3-Year ROIIC % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vineet Laboratories's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Vineet Laboratories's 3-Year ROIIC % falls into.
Vineet Laboratories's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 52.520304 (Mar. 2026) - 34.714888 (Mar. 2023) )
/
( 823.738 (Mar. 2026) - 776.627 (Mar. 2023) )
=
17.805416
/
47.111
=
37.79%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Vineet Laboratories (BOM:543298) has a 3-Year ROIIC % of 37.79 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vineet Laboratories and its competitors. This is 642% above median its historical median of 5.09. According to the industry distribution chart, Vineet Laboratories ranks #234 out of 1536 companies in the Chemicals industry, placing it in the top 15.2%.
Is Vineet Laboratories' 3-Year ROIIC % too high?
Vineet Laboratories' current 3-Year ROIIC % of 37.79 is 642% above median its 10-year median of 5.09. The Chemicals industry median 3-Year ROIIC % is 0.14. Vineet Laboratories' value of 37.79 is 26892.9% above this industry median. Based on the distribution chart, Vineet Laboratories ranks #234 out of 1536 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Vineet Laboratories has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' 3-Year ROIIC % compare to DOW?
According to the Chemicals industry distribution chart, Vineet Laboratories ranks #234 out of 1536 companies for 3-Year ROIIC %. This places Vineet Laboratories in the top 15% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 0.14. Vineet Laboratories' value of 37.79 is 26892.9% above this benchmark. While the company's 10-year median is 5.09 vs. the industry median of 0.14, Vineet Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Chemicals company?
The median 3-Year ROIIC % among Chemicals companies is 0.14, based on 1,536 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vineet Laboratories's current 3-Year ROIIC % of 37.79 is 26892.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Vineet Laboratories and its competitors. For the Chemicals industry, the median 3-Year ROIIC % is 0.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vineet Laboratories's current 3-Year ROIIC % is 37.79, which is 642% above median its own 10-year median of 5.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (BOM:543298) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹10.04, compared to a current price of ₹36.82 — trading 266.7% above its estimated fair value. The current 3-Year ROIIC % is 37.79, which is 642% above median its 10-year median of 5.09 and 26892.9% above the Chemicals industry median of 0.14. Vineet Laboratories' overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Vineet Laboratories (BOM:543298), the current 3-Year ROIIC % is 37.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vineet Laboratories (BOM:543298) Overvalued in 2026?
Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued.
The current stock price of ₹36.82 is trading 266.7% above its estimated GF Value™ of ₹10.04.
GuruFocus considers Vineet Laboratories to be Significantly Overvalued.
Key valuation signals for BOM:543298:
3-Year ROIIC %: 37.79 (642% above median its 10-year median of 5.09)
GF Value™: ₹10.04 vs. price of ₹36.82 (266.7% above fair value)
Industry Position: 26892.9% above the Chemicals median (#234 of 1536)
No single metric tells the full story. See the BOM:543298 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
56GF Score
Get the complete analysis for BOM:543298
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543298 has been successfully added to your 
